SMA News & Perspectives - January 28, 2019
Jan 28, 2019, 12:00 AM
We discuss how scientists have developed a new method to evaluate nutritional status of children with SMA. Also, Michael Morale discusses the question that many individuals with SMA are trying to answer. This question involves just how far our muscles will take us in the future. We’re fortunate to have Spinraza as our first treatment option, and with the possible pending approval of ZOLGENSMA, this question may be answered in the not so distant future.